StockData
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

Canopy Growth Corp

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72+0.00 (+0.38%)

Close on Oct 19, 2026

About Canopy Growth

Medicinal Chemicals & Botanical Products, SIC 2833

The company produces, distributes, and sells cannabis, hemp, and consumer goods. Its operations encompass adult-use cannabis, medical cannabis, and international cannabis markets, along with vaporizers and consumer wellness products under brands such as Storz & Bickel. The business operates across segments that include Canadian adult-use cannabis, Canadian medical cannabis, international cannabis markets, and consumer products. Its offerings include dried flower, extracts, and related vaporization equipment. The company serves medical patients seeking therapeutic cannabis solutions as well as adult recreational consumers through retail and wholesale distribution channels.

Geographically, the entity maintains commercial activities and operations across Canada, the United States, Germany, the United Kingdom, the Netherlands, and Australia. Its physical infrastructure includes production facilities, warehouses, and greenhouses, with business interests located in Ontario, Canada. The provided text does not identify a specific corporate headquarters location.

Summary of the business section of Canopy Growth's latest annual report, written by StockData.

Company profile

Company

Legal name
Canopy Growth Corp
Founded
2013
Headquarters
Smith Falls, A6
Address
1 Hershey Drive K7A0A8
Phone
(855) 558-9333
Employees
1,128, Mar 31, 2026
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
Z4
Fiscal year ends
March 31
Auditor
PKF OConnor Davies, LLP, New York, New York

Stock & identifiers

Ticker
CGC
Exchange
Nasdaq
IPO date
Apr 7, 2014
Shares outstanding
423M, Aug 5, 2026
Public float
$485.00M, Sep 30, 2025
Filer category
Accelerated filer
Stock splits
1-for-10 reverse, Dec 31, 2023; 1-for-10 reverse, Dec 20, 2023
SEC CIK
1737927
CUSIP
138035704
ISIN
US1380357046
LEI
529900CSD7NH1UBC9X07
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Luc MongeauChief Executive Officer, Director1,723,913
Thomas Carlton StewartSee Remarks588,412
Christelle GedeonSee Remarks692,162
Judy Eun Joo HongChief Financial Officer579,889
David Angelo LazzaratoDirector189,479
Joseph BayernDirector142,031
Theresa YanofskyDirector131,495
M. Shan AtkinsDirector143,421
Willy KruhDirector62,939

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026
Mr Mongeau
$3.62M$2.42M$1.88M$0$18
FY2025
Mr Klein
$5.01M-$5.60M$1.88M$0$17
FY2025
Mr Mongeau
$968.93K$561.39K$1.88M$0$17
FY2024
David Klein
$7.61M$11.21M$2.00M$3$25
FY2024
Mr Klein
$7.61M$11.21M$2.00M$3$25
FY2023
David Klein
$6.46M$534.35K$2.34M$6$23

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of March 31, 2026, Canopy Growth had 1,128 total employees, including 923 employees in Canada, as compared to 960 total employees as of March 31, 2025 including 728 employees in Canada.”

Corporate history

Events identified from SEC filings